Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesMethotrexate-Induced Hodgkin Disease in a Patient With Systemic Lupus Erythematosus
Journal of the American Osteopathic Association, 06/26/09
Sliesoraitis S et al. - The authors present a case of methotrexate-induced Hodgkin disease in a 48-year-old man with a history of systemic lupus erythematosus (SLE). Discontinuation of methotrexate facilitated Hodgkin disease reversal.
Sarunas Sliesoraitis, 06/27/09
| "Methotrexate-Induced Hodgkin Disease in a Patient With Systemic Lupus Erythematosus" is just a small report which I hope could lead to bigger future discoveries. Although so much has been achieved even in the last few years, there are several tumors waiting to be explored. EBV is one of the potential future targets for tumor treatment. If withdrawal of immune suppression leads to regression of tumor, then erradication or suppression of viral growth should potentially achieve more impressive results! Viral specific therapies rather than cell kill should lead to improved toxicity profile and improve ultimate survival. I do hope that you will enjoy our article. Thank you! Sarunas Sliesoraitis, DO, PharmD |
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Drugs for preventing malaria in travellers
Cochrane Reviews, 10/22/09
A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding
Clinical Therapeutics, 11/02/09
Incidence and causes of heparin-induced skin lesions
Canadian Medical Association Journal, 10/19/09
Sponsor
Article Search
Sponsor